Molecular NeuroImaging — New Haven, Connecticut

Molecular NeuroImaging is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Molecular NeuroImaging has participated in 6 clinical trials.

Therapeutic areas: Parkinson Disease, Alzheimer's Disease, Healthy.

Sponsors: Molecular NeuroImaging, Avid Radiopharmaceuticals, Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Molecular NeuroImaging?

Molecular NeuroImaging has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Molecular NeuroImaging conducted?

Molecular NeuroImaging has 6 clinical trials on record. Their work covers Parkinson Disease, Alzheimer's Disease, Healthy.

Is Molecular NeuroImaging accredited by Crixeo Health?

Molecular NeuroImaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Molecular NeuroImaging?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.